Calunsag, Rona C.
HRN: 23-64-60 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/04/2023
CEFTRIAXONE 1G (VIAL)
09/04/2023
09/10/2023
IVT
2gms
Q24
Bilateral Pneumonia
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes